IDYA
Price
$40.50
Change
-$1.03 (-2.48%)
Updated
May 17, 6:59 PM EST
85 days until earnings call
TNGX
Price
$7.52
Change
-$0.27 (-3.47%)
Updated
May 17, 6:59 PM EST
79 days until earnings call
Ad is loading...

IDYA vs TNGX

Header iconIDYA vs TNGX Comparison
Open Charts IDYA vs TNGXBanner chart's image
IDEAYA Biosciences
Price$40.50
Change-$1.03 (-2.48%)
Volume$529.14K
CapitalizationN/A
Tango Therapeutics
Price$7.52
Change-$0.27 (-3.47%)
Volume$268.65K
CapitalizationN/A
View a ticker or compare two or three
IDYA vs TNGX Comparison Chart

Loading...

IDYADaily Signal changed days agoGain/Loss if shorted
 
Show more...
TNGXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
IDYA vs. TNGX commentary
May 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IDYA is a StrongBuy and TNGX is a Sell.

COMPARISON
Comparison
May 19, 2024
Stock price -- (IDYA: $40.50 vs. TNGX: $7.52)
Brand notoriety: IDYA and TNGX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IDYA: 117% vs. TNGX: 68%
Market capitalization -- IDYA: $3.07B vs. TNGX: $803.48M
IDYA [@Biotechnology] is valued at $3.07B. TNGX’s [@Biotechnology] market capitalization is $803.48M. The market cap for tickers in the [@Biotechnology] industry ranges from $586.12B to $0. The average market capitalization across the [@Biotechnology] industry is $2.73B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IDYA’s FA Score shows that 0 FA rating(s) are green whileTNGX’s FA Score has 0 green FA rating(s).

  • IDYA’s FA Score: 0 green, 5 red.
  • TNGX’s FA Score: 0 green, 5 red.
According to our system of comparison, both IDYA and TNGX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IDYA’s TA Score shows that 5 TA indicator(s) are bullish while TNGX’s TA Score has 3 bullish TA indicator(s).

  • IDYA’s TA Score: 5 bullish, 4 bearish.
  • TNGX’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, IDYA is a better buy in the short-term than TNGX.

Price Growth

IDYA (@Biotechnology) experienced а -1.63% price change this week, while TNGX (@Biotechnology) price change was +5.84% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.41%. For the same industry, the average monthly price growth was +2.86%, and the average quarterly price growth was +60.72%.

Reported Earning Dates

IDYA is expected to report earnings on Aug 12, 2024.

TNGX is expected to report earnings on Aug 06, 2024.

Industries' Descriptions

@Biotechnology (+1.41% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for IDYA with price predictions.
OPEN
A.I.dvisor published
a Summary for TNGX with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
IDYA($3.07B) has a higher market cap than TNGX($803M). IDYA YTD gains are higher at: 13.828 vs. TNGX (-24.040).
IDYATNGXIDYA / TNGX
Capitalization3.07B803M382%
EBITDAN/AN/A-
Gain YTD13.828-24.040-58%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
TECHNICAL ANALYSIS
Technical Analysis
IDYATNGX
RSI
ODDS (%)
Bullish Trend 2 days ago
77%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
74%
Bullish Trend 2 days ago
75%
Momentum
ODDS (%)
Bearish Trend 2 days ago
79%
Bearish Trend 2 days ago
74%
MACD
ODDS (%)
Bullish Trend 2 days ago
84%
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
77%
Bullish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
79%
Advances
ODDS (%)
Bullish Trend 4 days ago
79%
Bullish Trend 4 days ago
84%
Declines
ODDS (%)
Bearish Trend 2 days ago
76%
Bearish Trend 2 days ago
82%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
83%
Aroon
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
84%
View a ticker or compare two or three
Ad is loading...
IDYADaily Signal changed days agoGain/Loss if shorted
 
Show more...
TNGXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TRCVX25.610.07
+0.27%
Nuveen Large Cap Value Idx Retire
AVUSX17.200.04
+0.23%
Avantis® U.S. Equity Institutional
MBVKX20.310.03
+0.15%
BlackRock Large Cap Focus Value K
QKBGX21.880.03
+0.14%
Federated Hermes MDT Balanced R6
FEMAX10.96N/A
N/A
First Eagle U.S. SMID Cap Opportunity A

IDYA and

Correlation & Price change

A.I.dvisor indicates that over the last year, IDYA has been loosely correlated with GRI. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if IDYA jumps, then GRI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IDYA
1D Price
Change %
IDYA100%
-2.48%
GRI - IDYA
54%
Loosely correlated
+1.82%
INAB - IDYA
47%
Loosely correlated
+0.98%
SNDX - IDYA
39%
Loosely correlated
-3.01%
TNGX - IDYA
36%
Loosely correlated
-3.47%
FATE - IDYA
36%
Loosely correlated
-5.80%
More

TNGX and

Correlation & Price change

A.I.dvisor indicates that over the last year, TNGX has been loosely correlated with AXON. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if TNGX jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TNGX
1D Price
Change %
TNGX100%
-3.47%
AXON - TNGX
41%
Loosely correlated
-0.57%
PSTX - TNGX
40%
Loosely correlated
-4.63%
MDGL - TNGX
39%
Loosely correlated
+1.33%
IDYA - TNGX
36%
Loosely correlated
-2.48%
ORMP - TNGX
36%
Loosely correlated
-1.29%
More